Showing 3911-3920 of 7368 results for "".
- First Ever SkinCeuticals Aesthetic Center for Men Opens in DChttps://practicaldermatology.com/news/first-ever-skinceuticals-aesthetic-center-for-men-opens-in-dc/2458654/SkinCeuticals cut the ribbon on their first ever brick-and-mortar Center for men in Washington, DC. The SkinCeuticals Aesthetic Center is located within W for Men at the Washington Institute of Dermatologic Laser Surgery. "Men are increasingly interested in looking and
- APP® Membership Now Has More Rewards: Three Syneron Candela Platformshttps://practicaldermatology.com/news/app-membership-now-has-more-rewards-three-syneron-candela-platforms/2458655/Syneron Medical Ltd. and Allergan plc are joining forces to offer three of Syneron Candela's body sculpting and skincare platforms to members of Allergan Partner Privileges® (APP®</
- New from Olay: Regenerist Micro-Sculpting Cream with SPF 30https://practicaldermatology.com/news/new-from-olay-regenerist-micro-sculpting-cream-with-spf-30/2458657/Olay introduced the newest member of the Regenerist family -- Regenerist Micro-Sculpting Cream with SPF 30 -- at the annual meeting of the American Academy of Dermatology in Washington, DC. Several studies presented here helped lay the groundw
- Medical Professionals, Practical Dermatology® Board Members, Recognized for Outstanding Work in Psoriatic Disease Fieldhttps://practicaldermatology.com/news/medical-professionals-practical-dermatology-board-members-recognized-for-outstanding-work-in-psoriatic-disease-field/2458661/Nominated by patients and colleagues, recipients of the first annual National Psoriasis Foundation Medical Professionals Awards exemplify the outstanding work being done in the psoriatic disease
- Cipher Pharmaceuticals Appoints New President and General Manager of US Businesshttps://practicaldermatology.com/news/cipher-pharmaceuticals-appoints-new-president-and-general-manager-of-us-business/2458662/Cipher Pharmaceuticals Inc. named Ralph Bohrer as President and General Manager of its US subsidiary. Mr. Bohrer is a seasoned pharmaceutical executive with 30 years of experience in sales and marketing leadership for growing dermatology companies. Prior to
- Syneron Candela Introducing New Technologies at the 2016 AAD Annual Meetinghttps://practicaldermatology.com/news/syneron-candela-introducing-new-technologies-at-the-2016-aad-annual-meeting/2458664/Syneron Medical Ltd., is launching three new products during the 2016 American Academy of Dermatology (AAD) meeting in Washington, DC. The launches include the new CO2RE Intima sy
- Envy Medical Launches SilkPeel Daily Dermal Optimizerhttps://practicaldermatology.com/news/envy-medical-launches-silkpeel-daily-dermal-optimizer/2458663/Envy Medical, Inc., is launching its SilkPeel® Daily Der al Optimizer at the American Academy of Dermatology (AAD) Annual Meeting taking place March 4-8 in Washington, DC. Building off of the professional SilkPeel Diamo
- Grooming Habits, Products May Affect Alopecia Riskhttps://practicaldermatology.com/news/grooming-habits-products-may-affect-alopecia-risk/2458671/Environmental factors --including weathering and grooming habits – may play a role in causing age-related alopecia, according to a new report in the International Journal of Women’s Dermatolog
- Novel Nanotechnology Delivery System May Offer New Approach to Skin Disease Treatmenthttps://practicaldermatology.com/news/novel-nanotechnology-delivery-system-may-offer-new-approach-to-skin-disease-treatment/2458675/A new nanotechnology-based delivery system may help activate the body's natural defense against free radicals and control a variety of skin conditions, report researchers from The Hebrew University of Jerusalem and Technion -- Israel Institute of Technology. Specifically, applyi
- Valeant Pharmaceuticals Announces Management And Business Updatehttps://practicaldermatology.com/news/valeant-pharmaceuticals-announces-management-and-business-update/2458677/J. Michael Pearson has returned as Valeant Pharmaceuticals International, Inc.’s chief executive officer following his recovery from severe pneumonia and other complications. Howard B. Schiller, Valeant's interim chief executive officer, will transition out of his current duties but wil